Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Patent Publication Number 20180325885
US 20180325885 A1Patent NumberUS 10555939 B2
Application Number15976808
Filled DateMay 10, 2018
Priority DateMay 19, 2009
Publication DateNov 15, 2018
Original AssigneeBristol Myers Squibb
Current AssigneeCelgene
Inventor/ApplicantsAnthony J. Tutino
Michael T. Kelly
Michael T. Kelly
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.